We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

DNA Mutations Shed in Blood Predicts Response to Immunotherapy in Patients with Cancer

News   Oct 03, 2017 | Original story from UCSD

 
DNA Mutations Shed in Blood Predicts Response to Immunotherapy in Patients with Cancer
 
 
 

RELATED ARTICLES

Common Disease Mechanism for ALS and Frontotemporal Dementia

News

Findings suggest mutations leading to accumulation of RNA-binding proteins to blame for disease, and could offer route for early diagnosis

READ MORE

Sprouty 1 and Sprouty 2 Offer Potential to Combat Cancer

News

Two molecules, Sprouty 1 and Sprouty 2, modify the survival of effector T cells and the development of memory CD8 T cells. These findings offer promising potential for immunotherapeutic strategies to combat cancer and chronic infections.

READ MORE

Liquid Biopsy Predicts Lymphoma Therapy Success Within Days

News

Being able to identify people who are responding well to therapy may spare them from unnecessary additional treatments.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE